Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Worldwide, 1 in 10 women of reproductive age suffer from a condition known as endometriosis. It’s an illness where tissue ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

There is a 10 per cent rise in endometriosis cases among women, with one in 10 women getting diagnosed with the condition per ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

A report reveals endometriosis leads to lower wages and job loss for women, highlighting workplace stigma and causing uproar ...

ONS data shows those with endometriosis lose £56 a month, Amy Peckham-Driver from Woodbridge has explained how this affects sufferers.

Endometriosis can be a brake on women's careers Endometriosis is a chronic, inflammatory, hormone-dependent gynecological disease that affects around 10% of women of childbearing age. The main ...

The Albanese government will announce half a billion dollars in women’s health investments, highlighting improved access to ...

However, while most of the integrated care boards (ICBs) – which decide who can have their egg freezing paid for by the NHS – ...

With one in every 10 women of reproductive age getting diagnosed with endometriosis, doctors have said early intervention and awareness can help reduce complications related to the painful condition ...

The Albanese government has announced half a billion in funding for women's health reforms in Australia, so what's the real ...